Mallinckrodt Hospital Products, Inc.(NASDAQ : CADX)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -2.92% | 158.01 | 0.7% | $1349.36m | |
| PFE | Pfizer Inc. | -0.89% | 33.52 | 0.9% | $1231.01m | |
| BMY | Bristol-Myers Squibb Co. | -1.35% | 61.26 | 1.0% | $864.73m | |
| MRK | Merck & Co., Inc. | -2.73% | 72.58 | 0.7% | $812.99m | |
| ABBV | AbbVie, Inc. | 0.28% | 107.63 | 1.9% | $810.79m | |
| LLY | Eli Lilly & Co. | 0.43% | 204.69 | 1.1% | $785.50m | |
| AZN | AstraZeneca Plc | -1.08% | 48.38 | 1.2% | $514.48m | |
| GSK | GlaxoSmithKline Plc | -2.24% | 33.61 | 0.2% | $264.35m | |
| NVS | Novartis AG | -0.87% | 85.96 | 0.2% | $189.07m | |
| SNY | Sanofi | 0.20% | 45.89 | 0.2% | $168.76m | |
| VTRS | Viatris, Inc. | -1.33% | 14.85 | 0.0% | $142.39m | |
| VERU | Veru, Inc. | -3.22% | 13.82 | 0.0% | $115.13m | |
| CVAC | CureVac NV | 1.43% | 94.30 | 0.0% | $107.78m | |
| VYNE | VYNE Therapeutics, Inc. | -5.45% | 7.46 | 0.0% | $94.74m | |
| NVO | Novo Nordisk A/S | -1.47% | 71.28 | 0.1% | $91.66m |
Company Profile
Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. On May 4, 2010 Cadence resubmitted a New Drug Application for its investigational product candidate, OFIRMEVTM (acetaminophen) injection for the treatment of pain and fever in adults and children. The FDA has assigned a new Prescription Drug User Fee Act (PDUFA) action date for OFIRMEV of November 4, 2010.